Luye Pharma Group Net Tangible Assets

As of the most recent data (June 2026), LYPHF shows a net tangible assets of $18B. That compares with $17B in the prior-year period — up 6.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYPHF's net tangible assets is now $18B (was $17B) — a 6.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Luye Pharma Group is outperforming or lagging.

Tracking LYPHF's net tangible assets over time shows whether Luye Pharma Group is scaling, shrinking, or reshaping that part of the business. The current reading is $18B That compares with $17B in the prior-year period — up 6.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Luye Pharma Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $18B) with ownership activity and broader fundamentals.